Answers are grounded in this paper and cite their sources.
Optogenetics reveals adrenergic neuron signaling enhances glioma proliferation in specific brain regions, suggesting increased tumor microenvironment interactions.
H3K27M-altered diffuse midline glioma (DMG) is a highly aggressive childhood cancer occurring in neuroanatomical locations of the central nervous system midline, including the pons, thalamus, and spinal cord. In the DMG microenvironment, glutamatergic and GABAergic neurons play critical roles in glioma progression through both neuronal activity-regulated secreted factors and direct connection via neuron-to-glioma synapses. However, the role of other subtypes of neuromodulatory neurons in glioma progression remains largely unexplored. Notably, in patients, DMGs often invade the locus coeruleus, a small pontine nucleus rich in adrenergic neurons, which project axons throughout the brain and release norepinephrine (NE). Here, we used patient-derived DMG cell lines and optogenetics to investigate how adrenergic neurons and NE influence DMG proliferation across different brain regions. In DMG monoculture, NE treatment increased proliferation and migration in some, which was mediated by the alpha1-adrenergic receptor, but not all patient-derived DMG cultures. Analysis of publicly available single-cell and single-nucleus RNA sequencing data revealed that the alpha1-adrenergic receptor subunit gene Adra1a1 is broadly expressed across various central nervous system tumors, albeit with heterogeneity. To further understand this heterogeneity, we co-cultured DMG cell lines with primary neurons and glial cells isolated from the cortex, brainstem, and thalamus of rat brains. Remarkably, NE-nonresponsive DMG cell lines became responsive to NE when co-cultured with brainstem neurons and glial cells, suggesting that the local microenvironment influences NE sensitivity. In vivo optogenetic stimulation of adrenergic neurons in the locus coeruleus promotes the proliferation of DMG in pons, further supporting the role of adrenergic signaling in DMG progression in a brainstem context. Taken together, these findings demonstrate that NE-driven DMG proliferation is modulated by the tumor microenvironment, highlighting the importance of brain region-specific neuronal and glial interactions in shaping tumor behavior and identifying adrenergic neurons as a newly appreciated neuron-glioma mechanism driving the growth of DMGs.
No takes yet. Share an insight, caveat, or question.
Byun et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: